![Geno Germano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geno Germano
Président chez
ENTERA BIO LTD.
Fortune : 423 580 $ au 30/06/2026
Profil
Geno J.
Germano currently serves as Independent Chairman at Entera Bio Ltd. since 2026, Independent Director at Precision BioSciences, Inc. since 2020, and Director at Harmony Biosciences Holdings, Inc. since 2026.
Former positions include President, Chief Executive Officer & Director at Elucida Oncology, Inc. from 2018 to 2024; Chairman at SAGE Therapeutics, Inc. from 2024 to 2025; Director roles at The Medicines Co., Biotechnology Innovation Organization, Zoetis, Inc. from 2012 to 2013, and Bioverativ, Inc.; Managing Director at Wyeth Australia Pty Ltd. and Wyeth New Zealand; President & General Manager-Specialty Care at Wyeth LLC in 2009; Group President-Global Innovative Pharma Business at Pfizer Inc. from 2014 to 2016; President-US Pharmaceuticals & Women's Health Care at Wyeth Pharmaceuticals LLC from 1984 to 2009; President at Precigen, Inc. from 2016 to 2017; Trustee at Albany College of Pharmacy & Health Sciences from 2008 to 2018; and Member of the Group of 50.
Education includes an undergraduate degree from Albany College of Pharmacy & Health Sciences, conferred in 1983.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 44 883 ( 0,19% ) | 352 780 $ | 30/06/2026 | |
ENTERA BIO LTD. 0,08% | 19/05/2026 | 40 000 ( 0,08% ) | 70 800 $ | 30/06/2026 |
| 14/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Geno Germano
| Sociétés | Poste | Début |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/03/2020 |
| ENTERA BIO LTD. | Président | 04/02/2026 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 14/05/2026 |
Anciens postes connus de Geno Germano
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Président | 31/07/2025 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Directeur Général | 01/06/2024 |
Albany College of Pharmacy & Health Sciences
 Albany College of Pharmacy & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/2018 |
| PRECIGEN, INC. | President | 10/03/2017 |
| PFIZER INC. | Corporate Officer/Principal | 01/02/2016 |
Formation de Geno Germano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
Albany College of Pharmacy & Health Sciences
Albany College of Pharmacy & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Group of 50 | |
Wyeth Australia Pty Ltd. | |
Entera Bio Ltd.
 Entera Bio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures flu medicines | Health Technology |
Wyeth New Zealand | |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
